Notice of updates

We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.

Read FSG

icon
HALO logo
halo search icon
Nova Eye Medical Ltd

AU$0.14

Price Change Indicator
-0.02 (-12.50%)
Nova Eye Medical Ltd
EYE · ASX

Nova Eye Medical Ltd

Start Trading EYE for Free

AU$0.14

Price Arrow-0.02 (-12.50%)
31/10/2025 03:57:16 PM
All-CompaniesAll-ConsensusGROWTH AUSHALO Consensus ValueHALO Earnings MomentumHALO GrowthHALO MomentumHALO Ords
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Nova Eye Medical Ltd Overview

EYE Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Weak

Balance Sheet

Very Weak

About EYE

icon
icon

Telephone

icon

Address

107 Rundle Street, Kent Town, South Australia (SA) 5067

Description

Nova Eye Medical Ltd. engages in developing suite of novel ophthalmic treatment technologies. It operates through the following segments: Faster Growing (iTrack), Emerging (2RT), and Core Ophthalmic Mark (Lasers and Ultrasounds). The iTrack segment offers catheter device that dilates the ocular structures compromised by glaucoma. The 2RT segment includes patent-protected with significant lead on competition and a per-use recurring fee business model. The Lasers and Ultrasounds segment represents testimony to the strength of the Ellex brand and was driven by growth in sales of the high-margin Ellex Tango and Ellex Tango Reflex glaucoma lasers. The company was founded by Giuseppe Canala and Victor Previn in 1985 and is headquartered in Kent Town, Australia.

EYE Price Chart

Key Stats

Market Cap

AU$45.57M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

100%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.09 - 0.19

Trade Value (12mth)

AU$13,299.00

1 week

3.23%

1 month

-3.03%

YTD

-8.57%

1 year

-5.88%

All time high

0.71

Key Fundamentals

EPS 3 yr Growth

-27.50%

EBITDA Margin

-23.00%

Operating Cashflow

-$6m

Free Cash Flow Return

-26.60%

ROIC

-39.80%

Interest Coverage

-42.60

Quick Ratio

1.80

Other Data

Shares Outstanding (Fully Diluted)

280m

HALO Sector

Healthcare

Next Company Report Date

02-Sep-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

EYE Announcements

Latest Announcements

DateAnnouncements
31 October 25
30 October 25
28 October 25
01 October 25
30 September 25

EYE Fundamentals

Per Share Records

Historical data

Forecast data

AUD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.1-0.04-0.04locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.1-0.04-0.04locklocklock
Growth
 %locklocklocklock-89.154.915.1locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

100%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Values and Recommendations

Key Stats

Consensus Score

lock

Recommendation

lock

EPS 1 month Change

lock

Quality Yield

lock

Falling Divs over next 2

lock

Halo Consensus Score

PEG Ratio

Consensus EPS Revisions

Short Selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

0

7 Day Change

0.00%

1 Month Change

0.00%

3 Months Change

0.00%

Dividend
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

EYE Shortsell

Related Companies

CSL - ASX
CSL Limited

CSL · ASX

CSL Limited

AU$179.13

Price Change Indicator

-0.43 (-0.239%)

RMD - ASX
ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh

RMD · ASX

ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh

AU$39.60

Price Change Indicator

0.71 (1.83%)

SIG - ASX
Sigma Healthcare Ltd

SIG · ASX

Sigma Healthcare Ltd

AU$3.12

Price Change Indicator

0.015 (0.484%)

Want to learn more?Frequently asked questions.
What is the current share price of Nova Eye Medical Ltd (EYE:ASX)?
Halo FAQ
The current share price of Nova Eye Medical Ltd (EYE:ASX) is AUD$0.14.
What is the 52-week high share price for Nova Eye Medical Ltd (EYE:ASX)?
Halo FAQ
The 52-week high share price for Nova Eye Medical Ltd (EYE:ASX) is AUD$0.19.
What is the 52-week low share price for Nova Eye Medical Ltd (EYE:ASX)?
Halo FAQ
The 52-week low share price for Nova Eye Medical Ltd (EYE:ASX) is AUD$0.09.
What is the dividend yield for Nova Eye Medical Ltd (EYE:ASX)?
Halo FAQ
Nova Eye Medical Ltd (EYE:ASX) does not pay a dividend.
What was Nova Eye Medical Ltd (EYE:ASX) last dividend payment?
Halo FAQ
The last dividend payment of Nova Eye Medical Ltd (EYE:ASX) is AUD$0.42.
What is the franking level for Nova Eye Medical Ltd (EYE:ASX)?
Halo FAQ
Nova Eye Medical Ltd (EYE:ASX) has a franking level of 100.00%.
In which sector is Nova Eye Medical Ltd (EYE:ASX) classified?
Halo FAQ
Nova Eye Medical Ltd (EYE:ASX) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Sign up for free